In HCC, our tested mutations in the POU domain of HNF1A that resulted in a loss of function regarding activity in the regulation of the HNF4A promoter caused a reduction in HNF4A mRNA expression, with the disruption of lipid metabolism, through the dysregulation of transcriptional networks. This evidence concerns the gene HNF4A and hepatocellular carcinoma.